Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage
A. Rucavado et al., Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage, THROMB HAEM, 85(4), 2001, pp. 710-715
Thrombocytopenia occurs in a number of patients bitten by Bothrops asper, a
species responsible for the majority of snakebites in Central America and
southern Mexico. In this work we describe the isolation of a new platelet-a
ggregating protein, named aspercetin, from the venom of B. asper, which ind
uces thrombocytopenia in mice. Isolation was carried out by a combination o
f ion-exchange chromatography on DEAE-Sepharose and affinity chromatography
on Affi-Gel Blue. Aspercetin is a disulfide-linked heterodimer, with a pi
of 4.5 and a molecular mass of 29,759 Da, detemined by MALDI-ESI mass spect
rometry. N-terminal sequence shows homology with a number of venom proteins
which belong to the C-type lectin family. Aspercetin has functional simila
rities with botrocetin, from B, jararaca venom, since it induces platelet a
ggregation only in the presence of plasma or purified von Willebrand factor
. Aspercetin-mediated platelet aggregation results from the interaction of
von Willebrand factor with platelet receptor GPIb. Aspercetin lacks anticoa
gulant effect and does not agglutinate erythrocytes, in contrast with other
representatives of the C-type lectin family isolated from snake venoms. Mo
reover, aspercetin is not lethal, nor does it induce myonecrosis, hemorrhag
e and edema. When injected intravenously or intramuscularly in mice it indu
ces a rapid, dose-dependent drop in platelet counts and prolongs the bleedi
ng time, suggesting that it may play a role in the thrombocytopenia that de
velops in a number of B, asper envenomations. Moreover, mice injected intra
venously with aspercetin and then receiving an intradermal injection of B,
asper hemorrhagic metalloproteinase BaP1 develop a larger hemorrhagic lesio
n than mice receiving only BaP1. This suggests that aspercetin, by reducing
platelet numbers, may contribute to the hemorrhagic effect characteristic
of B, asper envenomations.